Managing the Surge of Diabetes and Obesity: Improving Outcomes in Diverse Populations
San Francisco, CA: September 22, 2012 Marriott Union Square
Dallas, TX: Saturday, November 3, 2012 Renaissance Dallas Hotel
Miami, FL: December 8, 2012 JW Marriott Hotel Miami
At the conclusion of this educational symposium, the participants should be able to:
- Describe the epidemiology (both current and future projections) of diabetes and obesity in the United States with an emphasis on diverse populations
- Identify strategies to improve treatment and clinical outcomes for diverse patients with diabetes by better understanding cultural differences
- Apply a comprehensive care approach, including obesity interventions, when developing treatment plans for patients with type 2 diabetes
- Compare and contrast current and emerging therapies in addressing the pathophysiology of type 2 diabetes
- Describe the diagnostic and other criteria to consider in determining when and how insulin therapies should be used
UT Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UT Southwestern Medical Center designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NOTE: All other clinicians who attend this symposium (PAs, NPs, RNs, dietitians, etc.) will receive an attendance certificate indicating that the activity was designated for 4.25 AMA PRA Category 1 Credits™.
Conflict of Interest
It is UT Southwestern’s policy that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed in the course materials.
Discussion of Off-Label Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be “off-label” use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.